LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Molecular glue CELMoD compounds are regulators of cereblon conformation.

Watson, Edmond R / Novick, Scott / Matyskiela, Mary E / Chamberlain, Philip P / H de la Peña, Andres / Zhu, Jinyi / Tran, Eileen / Griffin, Patrick R / Wertz, Ingrid E / Lander, Gabriel C

Science (New York, N.Y.)

2022  Volume 378, Issue 6619, Page(s) 549–553

Abstract: Cereblon (CRBN) is a ubiquitin ligase (E3) substrate receptor protein co-opted by CRBN E3 ligase modulatory drug (CELMoD) agents that target therapeutically relevant proteins for degradation. Prior crystallographic studies defined the drug-binding site ... ...

Abstract Cereblon (CRBN) is a ubiquitin ligase (E3) substrate receptor protein co-opted by CRBN E3 ligase modulatory drug (CELMoD) agents that target therapeutically relevant proteins for degradation. Prior crystallographic studies defined the drug-binding site within CRBN's thalidomide-binding domain (TBD), but the allostery of drug-induced neosubstrate binding remains unclear. We performed cryo-electron microscopy analyses of the DNA damage-binding protein 1 (DDB1)-CRBN apo complex and compared these structures with DDB1-CRBN in the presence of CELMoD compounds alone and complexed with neosubstrates. Association of CELMoD compounds to the TBD is necessary and sufficient for triggering CRBN allosteric rearrangement from an open conformation to the canonical closed conformation. The neosubstrate Ikaros only stably associates with the closed CRBN conformation, illustrating the importance of allostery for CELMoD compound efficacy and informing structure-guided design strategies to improve therapeutic efficacy.
MeSH term(s) Adaptor Proteins, Signal Transducing/chemistry ; Cryoelectron Microscopy ; Thalidomide/chemistry ; Ubiquitin-Protein Ligases/chemistry ; Protein Domains ; Allosteric Regulation
Chemical Substances Adaptor Proteins, Signal Transducing ; CRBN protein, human ; Thalidomide (4Z8R6ORS6L) ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
Language English
Publishing date 2022-11-03
Publishing country United States
Document type Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID 128410-1
ISSN 1095-9203 ; 0036-8075
ISSN (online) 1095-9203
ISSN 0036-8075
DOI 10.1126/science.add7574
Shelf mark
Zs.A 27: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MG 77: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top